Botulinum Toxin Market Size, Share & Trends Analysis Report By Product Type (Type A, Type B), By Application (Therapeutic, Aesthetic), By End-use (Dermatology Clinics, Cosmetic Centers & Medspas), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Botulinum Toxin Market: Methodology And Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Product Type
                       1.1.2 Application
                       1.1.3 End-Use
                       1.1.4 Regional Scope
                       1.1.5 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information Or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                   1.7 List Of Secondary Sources
                   1.8 List Of Primary Sources
                   1.9 List Of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective - 1
                       1.10.2 Objective - 2
                       1.10.3 Objective - 3
Chapter 2 Botulinum Toxin Market: Executive Summary
                   2.1 Market Snapshot
                   2.2 Segment Snapshot
                   2.3 Competitive Landscape Snapshot
Chapter 3 Botulinum Toxin Market: Variables, Trends, & Scope
                   3.1 Market Segmentation And Scope
                   3.2 Market Dynamics
                       3.2.1 Market Driver Analysis
                           3.2.2.1 Increasing Number Of Patients Having Neurological Disorders
                           3.2.2.2 Rising Preference For Non-Invasive Or Minimally Invasive Procedures
                           3.2.2.3 Increasing Concern Regarding Aesthetic Appearance In 40-54 Age Group Has Increased The Adoption Rate
                       3.2.2 Market Restraint Analysis
                           3.2.2.1 High Cost Of Cosmetic Procedure
                   3.3 Botulinum Toxin: Market Analysis Tools
                       3.3.1 Industry Analysis - Porter’s
                       3.3.2 Pestel Analysis
                   3.4 COVID-19 Impact Analysis
Chapter 4 Botulinum Toxin Market: Product Type Segment Analysis
                   4.1 Botulinum Toxin: Product Type Market Share Analysis, 2023 & 2030
                   4.2 Type A
                       4.2.1 Type A Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                           4.2.1.1 Botox
                           4.2.1.2 Dysport
                           4.2.1.3 Xeomin
                           4.2.1.4 Others
                       4.2.2 Type B
                           4.2.2.1 Type B Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 5 Botulinum Toxin Market: Application Segment Analysis
                   5.1 Botulinum Toxin: Application Market Share Analysis, 2023 & 2030
                   5.2 Therapeutic
                       5.2.1 Therapeutic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                           5.2.1.1 Chronic Migraine
                           5.2.1.2 Overactive Bladder
                           5.2.1.3 Cervical Dystonia
                           5.2.1.4 Spasticity
                           5.2.1.5 Others
                   5.3 Aesthetic
                       5.3.1 Aesthetic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                           5.3.1.1 Glabellar Lines
                           5.3.1.2 Crow's Feet
                           5.3.1.3 Forehead Lines
                           5.3.1.4 Others
Chapter 6 Botulinum Toxin Market: End-Use Segment Analysis
                   6.1 Botulinum Toxin: End-Use Market Share Analysis, 2023 & 2030
                   6.2 Hospitals
                       6.2.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                   6.3 Dermatology Clinics
                       6.3.1 Dermatology Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                   6.4 Spas And Cosmetic Centers
                       6.4.1 Spas And Cosmetic Centers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 7 Botulinum Toxin Market: Regional Analysis
                   7.1 Botulinum Toxin: Regional Market Share Analysis, 2023 & 2030
                   7.2 North America
                       7.2.1 North America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.2.2 U.S.
                           7.2.2.1 Key Country Dynamics
                           7.2.2.2 U.S. Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.2.3 Canada
                           7.2.3.1 Key Country Dynamics
                           7.2.3.2 Canada Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                   7.3 Europe
                       7.3.1 Europe Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.3.2 UK
                           7.3.2.1 Key Country Dynamics
                           7.3.2.2 UK Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.3.3 Germany
                           7.3.3.1 Key Country Dynamics
                           7.3.3.2 Germany Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.3.4 France
                           7.3.4.1 Key Country Dynamics
                           7.3.4.2 France Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.3.5 Italy
                           7.3.5.1 Key Country Dynamics
                           7.3.5.2 Italy Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.3.6 Spain
                           7.3.6.1 Key Country Dynamics
                           7.3.6.2 Spain Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.3.7 Denmark
                           7.3.7.1 Key Country Dynamics
                           7.3.7.2 Denmark Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.3.8 Sweden
                           7.3.8.1 Key Country Dynamics
                           7.3.8.2 Sweden Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.3.9 Norway
                           7.3.9.1 Key Country Dynamics
                           7.3.9.2 Norway Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                   7.4 Asia Pacific
                       7.4.1 Asia Pacific Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.4.2 China
                           7.4.2.1 Key Country Dynamics
                           7.4.2.2 China Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.4.3 India
                           7.4.3.1 Key Country Dynamics
                           7.4.3.2 India Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.4.4 Japan
                           7.4.4.1 Key Country Dynamics
                           7.4.4.2 Japan Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.4.5 South Korea
                           7.4.5.1 Key Country Dynamics
                           7.4.5.2 South Korea Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.4.6 Australia
                           7.4.6.1 Key Country Dynamics
                           7.4.6.2 Australia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.4.7 Thailand
                           7.4.7.1 Key Country Dynamics
                           7.4.7.2 Thailand Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                   7.5 Latin America
                       7.5.1 Latin America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.5.2 Brazil
                           7.5.2.1 Key Country Dynamics
                           7.5.2.2 Brazil Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.5.3 Mexico
                           7.5.3.1 Key Country Dynamics
                           7.5.3.2 Mexico Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.5.4 Argentina
                           7.6.4.1 Key Country Dynamics
                           7.6.4.2 Argentina Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                   7.6 MEA
                       7.6.1 MEA Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.6.2 South Africa
                           7.6.2.1 Key Country Dynamics
                           7.6.2.2 South Africa Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.6.3 Saudi Arabia
                           7.6.3.1 Key Country Dynamics
                           7.6.3.2 Saudi Arabia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.6.4 UAE
                           7.6.4.1 Key Country Dynamics
                           7.6.4.2 UAE Botulinum Toxin Market, 2018 - 2030 (USD Billion)
                       7.6.5 Kuwait
                           7.6.5.1 Key Country Dynamics
                           7.6.5.2 Kuwait Botulinum Toxin Market, 2018 - 2030 (USD Billion)
Chapter 8 Company Profiles
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Botulinum Toxin- Market Share Analysis
                   8.3. Ipsen Group
                       8.3.1 Company Overview
                       8.3.2 Financial Performance
                       8.3.3 Product Benchmarking
                       8.3.4 Strategic Initiatives
                   8.4. Allergen Inc.
                       8.4.1 Company Overview
                       8.4.2 Financial Performance
                       8.4.3 Product Benchmarking
                       8.4.4 Strategic Initiatives
                   8.5 Medy-Tox, Inc.
                       8.5.1 Company Overview
                       8.5.2 Financial Performance
                       8.5.3 Product Benchmarking
                       8.5.4 Strategic Initiatives
                   8.6 Metabiologics
                       8.6.1 Company Overview
                       8.6.2 Financial Performance
                       8.6.3 Strategic Initiatives
                   8.7 Merz Pharma
                       8.7.1 Company Overview
                       8.7.2 Financial Performance
                       8.7.3 Product Benchmarking
                       8.7.4 Strategic Initiatives
                   8.8 US Worldmeds
                       8.8.1 Company Overview
                       8.8.2 Financial Performance
                       8.8.3 Product Benchmarking
                       8.8.4 Strategic Initiatives
                   8.9 Evolus
                       8.9.1 Company Overview
                       8.9.2 Financial Performance
                       8.9.3 Product Benchmarking
                       8.9.4 Strategic Initiatives
                   8.10 Galderma
                       8.10.1 Company Overview
                       8.10.2 Financial Performance
                       8.10.3 Product Benchmarking
                       8.10.4 Strategic Initiatives
                   8.11 Lanzhou Institute Of Biological Products
                       8.11.1 Company Overview
                       8.11.2 Financial Performance
                       8.11.3 Product Benchmarking
                       8.11.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Strategic collaborations by key players

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Botulinum toxin market snapshot (2023)
Fig. 10 Botulinum toxin market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s Five Forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Botulinum toxin market product type outlook: Segment dashboard
Fig. 17 Botulinum toxin market: product type movement analysis
Fig. 18 Type A market, 2018 - 2030 (USD Billion)
Fig. 19 Type B market, 2018 - 2030 (USD Billion)
Fig. 20 Botulinum toxin market application outlook: Segment dashboard
Fig. 21 Botulinum toxin market: Application movement analysis
Fig. 22 Therapeutic market, 2018 - 2030 (USD Billion)
Fig. 23 Aesthetic market, 2018 - 2030 (USD Billion)
Fig. 24 Botulinum toxin market end-use outlook: Segment dashboard
Fig. 25 Botulinum toxin market: End-use movement analysis
Fig. 26 Hospitals market, 2018 - 2030 (USD Billion)
Fig. 27 Dermatology clinics market, 2018 - 2030 (USD Billion)
Fig. 28 Cosmetic centers and medspas market, 2018 - 2030 (USD Billion)
Fig. 29 Regional market: Key takeaways
Fig. 30 Regional outlook: 2023 & 2030
Fig. 31 North America market, 2018 - 2030 (USD Billion)
Fig. 32 U.S. market, 2018 - 2030 (USD Billion)
Fig. 33 Key country dynamics
Fig. 34 Canada market, 2018 - 2030 (USD Billion)
Fig. 35 Key country dynamics
Fig. 36 Europe market, 2018 - 2030
Fig. 37 UK market, 2018 - 2030 (USD Billion)
Fig. 38 Key country dynamics
Fig. 39 Germany market, 2018 - 2030 (USD Billion)
Fig. 40 Key country dynamics
Fig. 41 France market, 2018 - 2030 (USD Billion)
Fig. 42 Key country dynamics
Fig. 43 Italy market, 2018 - 2030 (USD Billion)
Fig. 44 Key country dynamics
Fig. 45 Spain market, 2018 - 2030 (USD Billion)
Fig. 46 Key country dynamics
Fig. 47 Denmark market, 2018 - 2030 (USD Billion)
Fig. 48 Key country dynamics
Fig. 49 Sweden market, 2018 - 2030 (USD Billion)
Fig. 50 Key country dynamics
Fig. 51 Norway market, 2018 - 2030 (USD Billion)
Fig. 52 Key country dynamics
Fig. 53 Asia Pacific market, 2018 - 2030 (USD Billion)
Fig. 54 China market, 2018 - 2030 (USD Billion)
Fig. 55 Key country dynamics
Fig. 56 Japan market, 2018 - 2030 (USD Billion)
Fig. 57 Key country dynamics
Fig. 58 India market, 2018 - 2030 (USD Billion)
Fig. 59 Key country dynamics
Fig. 60 South Korea market, 2018 - 2030 (USD Billion)
Fig. 61 Key country dynamics
Fig. 62 Australia market, 2018 - 2030 (USD Billion)
Fig. 63 Key country dynamics
Fig. 64 Thailand market, 2018 - 2030 (USD Billion)
Fig. 65 Key country dynamics
Fig. 66 Latin America market, 2018 - 2030 (USD Billion)
Fig. 67 Brazil market, 2018 - 2030 (USD Billion)
Fig. 68 Key country dynamics
Fig. 69 Mexico market, 2018 - 2030 (USD Billion)
Fig. 70 Key country dynamics
Fig. 71 Argentina market, 2018 - 2030 (USD Billion)
Fig. 72 Key country dynamics
Fig. 73 MEA market, 2018 - 2030 (USD Billion)
Fig. 74 South Africa market, 2018 - 2030 (USD Billion)
Fig. 75 Key country dynamics
Fig. 76 Saudi Arabia market, 2018 - 2030 (USD Billion)
Fig. 77 Key country dynamics
Fig. 78 UAE market, 2018 - 2030 (USD Billion)
Fig. 79 Key country dynamics
Fig. 80 Kuwait market, 2018 - 2030 (USD Billion)
Fig. 81 Key country dynamics